Related Experiment Video
Updated: Aug 30, 2026
09:37
Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
Published on: December 4, 2021
Introducing the use of sterile maggots into a primary care trust: overcoming barriers
Mair Fear1, Richard Warrell, Lynn Allum
1Plymouth Primary Care Trust. Mair.Fear@pcs-tr.swest.nhs.uk
British Journal of Community Nursing
|October 11, 2003
Abstract:
Larval therapy has been available to patients in hospital where there has been a clinical need. Not all primary care trusts realize the clinical and cost effectiveness of this treatment, or if they do, are prepared to recognise funding to allow patients to receive this treatment in the privacy of their own home. Funding can be an issue as can instigating changes in practice, particularly when there are clinicians and managers who have an aversion to the therapy.
